HighTower Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.72M | Sell |
21,025
-13,719
| -39% | -$3.42M | 0.01% | 1225 |
|
|
2025
Q4 | $8.37M | Buy |
34,744
+1,377
| +4% | +$352K | 0.01% | 933 |
|
|
2025
Q3 | $9.15M | Sell |
33,367
-3,638
| -10% | -$994K | 0.01% | 885 |
|
|
2025
Q2 | $9.55M | Sell |
37,005
-2,669
| -7% | -$637K | 0.01% | 819 |
|
|
2025
Q1 | $8.88M | Buy |
39,674
+6,764
| +21% | +$1.58M | 0.01% | 812 |
|
|
2024
Q4 | $7.53M | Buy |
32,910
+3,690
| +13% | +$888K | 0.01% | 875 |
|
|
2024
Q3 | $7.1M | Buy |
29,220
+1,708
| +6% | +$382K | 0.01% | 891 |
|
|
2024
Q2 | $5.27M | Buy |
27,512
+3,124
| +13% | +$634K | 0.01% | 985 |
|
|
2024
Q1 | $4.84M | Buy |
24,388
+287
| +1% | +$52.6K | 0.01% | 981 |
|
|
2023
Q4 | $4.14M | Sell |
24,101
-24,821
| -51% | -$3.81M | 0.01% | 1070 |
|
|
2023
Q3 | $7.21M | Buy |
48,922
+4,959
| +11% | +$897K | 0.01% | 772 |
|
|
2023
Q2 | $9.61M | Sell |
43,963
-507
| -1% | -$113K | 0.02% | 663 |
|
|
2023
Q1 | $9.76M | Buy |
44,470
+1,540
| +4% | +$334K | 0.02% | 635 |
|
|
2022
Q4 | $8.9M | Sell |
42,930
-268
| -0.6% | -$58.9K | 0.02% | 652 |
|
|
2022
Q3 | $9.41M | Sell |
43,198
-10,560
| -20% | -$2.4M | 0.03% | 583 |
|
|
2022
Q2 | $11.3M | Sell |
53,758
-18,380
| -25% | -$3.91M | 0.03% | 533 |
|
|
2022
Q1 | $17.5M | Sell |
72,138
-4,277
| -6% | -$1.03M | 0.04% | 424 |
|
|
2021
Q4 | $19.9M | Buy |
76,415
+25,531
| +50% | +$6.62M | 0.04% | 381 |
|
|
2021
Q3 | $13.4M | Buy |
50,884
+299
| +0.6% | +$81.8K | 0.04% | 431 |
|
|
2021
Q2 | $12.4M | Buy |
50,585
+1,934
| +4% | +$407K | 0.04% | 446 |
|
|
2021
Q1 | $9.51M | Buy |
48,651
+1,821
| +4% | +$365K | 0.03% | 500 |
|
|
2020
Q4 | $9.89M | Buy |
46,830
+12,314
| +36% | +$2.46M | 0.04% | 376 |
|
|
2020
Q3 | $5.9M | Buy |
34,516
+9,139
| +36% | +$1.69M | 0.03% | 494 |
|
|
2020
Q2 | $4.88M | Sell |
25,377
-1,502
| -6% | -$246K | 0.03% | 521 |
|
|
2020
Q1 | $3.95M | Sell |
26,879
-32,587
| -55% | -$5.19M | 0.03% | 522 |
|
|
2019
Q4 | $9.2M | Buy |
59,466
+7,482
| +14% | +$1.08M | 0.05% | 359 |
|
|
2019
Q3 | $7.01M | Buy |
51,984
+2,106
| +4% | +$276K | 0.04% | 441 |
|
|
2019
Q2 | $6.1M | Sell |
49,878
-9
| -0% | -$997 | 0.04% | 489 |
|
|
2019
Q1 | $5.13M | Sell |
49,887
-14,478
| -22% | -$1.49M | 0.03% | 492 |
|
|
2018
Q4 | $7.33M | Sell |
64,365
-627
| -1% | -$67.2K | 0.06% | 349 |
|
|
2018
Q3 | $7.5M | Sell |
64,992
-3,317
| -5% | -$363K | 0.05% | 377 |
|
|
2018
Q2 | $7.02M | Sell |
68,309
-401
| -0.6% | -$40.6K | 0.06% | 385 |
|
|
2018
Q1 | $6.81M | Sell |
68,710
-191
| -0.3% | -$18K | 0.06% | 369 |
|
|
2017
Q4 | $5.83M | Sell |
68,901
-1,506
| -2% | -$124K | 0.05% | 422 |
|
|
2017
Q3 | $5.4M | Buy |
70,407
+1,084
| +2% | +$82.9K | 0.05% | 438 |
|
|
2017
Q2 | $5.38M | Sell |
69,323
-497
| -0.7% | -$35.6K | 0.05% | 435 |
|
|
2017
Q1 | $5.01M | Buy |
69,820
+10,215
| +17% | +$706K | 0.05% | 431 |
|
|
2016
Q4 | $3.69M | Buy |
59,605
+2,007
| +3% | +$123K | 0.04% | 495 |
|
|
2016
Q3 | $3.73M | Buy |
57,598
+468
| +0.8% | +$31.2K | 0.04% | 454 |
|
|
2016
Q2 | $3.61M | Sell |
57,130
-4,728
| -8% | -$279K | 0.05% | 431 |
|
|
2016
Q1 | $3.57M | Buy |
+61,858
| New | +$3.5M | 0.01% | 496 |
|
|
2015
Q4 | – | Sell |
-51,790
| Closed | -$2.69M | – | 2127 |
|
|
2015
Q3 | $2.69M | Buy |
51,790
+1,963
| +4% | +$106K | 0.04% | 502 |
|
|
2015
Q2 | $2.81M | Buy |
+49,827
| New | +$3.14M | 0.05% | 438 |
|
|
2015
Q1 | – | Sell |
-46,389
| Closed | -$2.6M | – | 1684 |
|
|
2014
Q4 | $2.6M | Buy |
46,389
+9,389
| +25% | +$490K | 0.04% | 491 |
|
|
2014
Q3 | $1.82M | Buy |
37,000
+1,332
| +4% | +$67.8K | 0.03% | 587 |
|
|
2014
Q2 | $1.81M | Buy |
35,668
+20,587
| +137% | +$1.02M | 0.03% | 591 |
|
|
2014
Q1 | $696K | Buy |
+15,081
| New | +$677K | 0.01% | 865 |
|
Other funds holding RMD
VCM
VPM
DAM
HighTower Advisors's RMD Position: Q1 2026 in Review
HighTower Advisors reduced its ResMed (RMD) stake by 39% in Q1 2026, selling an estimated $3.42M and leaving 21,025 shares worth $4.72M. The position accounts for 0.01% of the portfolio, ranked #1225.
HighTower Advisors first reported a position in RMD in Q1 2014 and has held it in 47 quarters since. The position peaked at $19.9M in Q4 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- HighTower Advisors held 21,025 shares of ResMed worth $4.72M as of Q1 2026.
- HighTower Advisors sold 13,719 ResMed shares in Q1 2026, an estimated $3.42M.
- ResMed made up 0.01% of HighTower Advisors's portfolio in Q1 2026, its #1225 holding.
- HighTower Advisors first reported a position in ResMed in Q1 2014 and has held it in 47 quarters since.
- HighTower Advisors's ResMed position peaked at $19.9M in Q4 2021.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.